Bleakley Financial Group’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,359
Closed -$506K 1036
2024
Q4
$506K Buy
4,359
+96
+2% +$12.1K 0.02% 620
2024
Q3
$576K Buy
4,263
+152
+4% +$20.3K 0.02% 560
2024
Q2
$558K Buy
4,111
+69
+2% +$9.39K 0.02% 577
2024
Q1
$522K Buy
4,042
+90
+2% +$10.9K 0.02% 604
2023
Q4
$452K Buy
3,952
+150
+4% +$15K 0.01% 621
2023
Q3
$346K Sell
3,802
-1,260
-25% -$130K 0.01% 644
2023
Q2
$570K Buy
5,062
+1,060
+26% +$112K 0.02% 551
2023
Q1
$419K Sell
4,002
-289
-7% -$30.2K 0.01% 612
2022
Q4
$474K Buy
+4,291
New +$450K 0.02% 568

Other funds holding XYL

Bleakley Financial Group's XYL Position: Q1 2025 in Review

Bleakley Financial Group sold out of Xylem (XYL) in Q1 2025, closing a stake of 4,359 shares — an estimated $506K sold.

Bleakley Financial Group first reported a position in XYL in Q4 2022 and held it in 9 quarters. The position peaked at $576K in Q3 2024. 1,026 funds tracked by Wall St. Rank hold XYL as of Q1 2025.

  • Bleakley Financial Group reported no remaining Xylem position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 4,359 Xylem shares in Q1 2025, an estimated $506K.
  • Bleakley Financial Group first reported a position in Xylem in Q4 2022 and held it in 9 quarters.
  • Bleakley Financial Group's Xylem position peaked at $576K in Q3 2024.
  • 1,026 funds tracked by Wall St. Rank held Xylem as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.